Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 154

1.

Sorafenib versus surgical resection for hepatocellular carcinoma with macrovascular invasion: a propensity score analysis.

Costentin CE, Decaens T, Laurent A, Nault JC, Paule B, Letoublon C, Luciani A, Calderaro J, Adam R, Bricault I, Amaddeo G, Cherqui D, Mallat A, Samuel D, Duvoux C, Ganne-Carrié N, Roudot-Thoraval F, Vibert E.

Liver Int. 2017 Jun 13. doi: 10.1111/liv.13491. [Epub ahead of print]

PMID:
28609020
2.

Three-dimensional Image Fusion Guidance for Transjugular Intrahepatic Portosystemic Shunt Placement.

Tacher V, Petit A, Derbel H, Novelli L, Vitellius M, Ridouani F, Luciani A, Rahmouni A, Duvoux C, Salloum C, Chiaradia M, Kobeiter H.

Cardiovasc Intervent Radiol. 2017 May 17. doi: 10.1007/s00270-017-1699-9. [Epub ahead of print]

PMID:
28516271
3.

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.

Yoshida EM, Kwo P, Agarwal K, Duvoux C, Durand F, Peck-Radosavljevic M, Lilly L, Willems B, Vargas H, Kumar P, Brown RS Jr, Horsmans Y, De-Oertel S, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault N, Rizzetto M, Müllhaupt B.

Ann Hepatol. 2017 May - Jun;16(3):375-381. doi: 10.5604/16652681.1235480.

PMID:
28425407
4.

EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice.

Aubé C, Oberti F, Lonjon J, Pageaux G, Seror O, N'Kontchou G, Rode A, Radenne S, Cassinotto C, Vergniol J, Bricault I, Leroy V, Ronot M, Castera L, Michalak S, Esvan M, Vilgrain V; CHIC Group.

Liver Int. 2017 Mar 27. doi: 10.1111/liv.13429. [Epub ahead of print]

PMID:
28346737
5.

Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.

Neuberger JM, Bechstein WO, Kuypers DR, Burra P, Citterio F, De Geest S, Duvoux C, Jardine AG, Kamar N, Krämer BK, Metselaar HJ, Nevens F, Pirenne J, Rodríguez-Perálvarez ML, Samuel D, Schneeberger S, Serón D, Trunečka P, Tisone G, van Gelder T.

Transplantation. 2017 Apr;101(4S Suppl 2):S1-S56. doi: 10.1097/TP.0000000000001651.

PMID:
28328734
6.

ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients.

Belli LS, Duvoux C, Berenguer M, Berg T, Coilly A, Colle I, Fagiuoli S, Khoo S, Pageaux GP, Puoti M, Samuel D, Strazzabosco M.

J Hepatol. 2017 Mar 18. pii: S0168-8278(17)30140-X. doi: 10.1016/j.jhep.2017.03.006. [Epub ahead of print] Review.

PMID:
28323126
7.

Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.

Menahem B, Lubrano J, Duvoux C, Mulliri A, Alves A, Costentin C, Mallat A, Launoy G, Laurent A.

Liver Transpl. 2017 Jun;23(6):836-844. doi: 10.1002/lt.24758. Review.

PMID:
28295992
8.

[De novo cancer after solid organ transplantation: Epidemiology, prognosis and management].

Guillemin A, Rousseau B, Neuzillet C, Joly C, Boussion H, Grimbert P, Compagnon P, Duvoux C, Tournigand C.

Bull Cancer. 2017 Mar;104(3):245-257. doi: 10.1016/j.bulcan.2016.12.008. Epub 2017 Feb 23. Review. French.

PMID:
28237352
9.

Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.

Costentin CE, Amaddeo G, Decaens T, Boudjema K, Bachellier P, Muscari F, Salamé E, Bernard PH, Francoz C, Dharancy S, Vanlemmens C, Radenne S, Dumortier J, Hilleret MN, Chazouillères O, Pageaux GP, Calderaro J, Laurent A, Roudot-Thoraval F, Duvoux C; Liver Transplantation French Study Group.

Liver Int. 2017 May;37(5):717-726. doi: 10.1111/liv.13388. Epub 2017 Mar 24.

PMID:
28199760
10.

External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry.

Winter A, Féray C, Audureau E, Écochard R, Jacquelinet C, Roudot-Thoraval F, Duvoux C, Daurès JP, Landais P.

Liver Int. 2017 Jan 31. doi: 10.1111/liv.13378. [Epub ahead of print]

PMID:
28140515
11.

Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial.

Saliba F, Duvoux C, Gugenheim J, Kamar N, Dharancy S, Salamé E, Neau-Cransac M, Durand F, Houssel-Debry P, Vanlemmens C, Pageaux G, Hardwigsen J, Eyraud D, Calmus Y, Di Giambattista F, Dumortier J, Conti F.

Am J Transplant. 2017 Jan 30. doi: 10.1111/ajt.14212. [Epub ahead of print]

PMID:
28133906
12.

Long-term outcome in liver transplantation candidates with portopulmonary hypertension.

Savale L, Sattler C, Coilly A, Conti F, Renard S, Francoz C, Bouvaist H, Feray C, Borentain P, Jaïs X, Montani D, Parent F, O'Connell C, Hervé P, Humbert M, Simonneau G, Samuel D, Calmus Y, Duvoux C, Durand F, Duclos-Vallée JC, Sitbon O.

Hepatology. 2017 May;65(5):1683-1692. doi: 10.1002/hep.28990. Epub 2017 Mar 14.

PMID:
27997987
13.

Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.

Notarpaolo A, Layese R, Magistri P, Gambato M, Colledan M, Magini G, Miglioresi L, Vitale A, Vennarecci G, Ambrosio CD, Burra P, Di Benedetto F, Fagiuoli S, Colasanti M, Maria Ettorre G, Andreoli A, Cillo U, Laurent A, Katsahian S, Audureau E, Roudot-Thoraval F, Duvoux C.

J Hepatol. 2017 Mar;66(3):552-559. doi: 10.1016/j.jhep.2016.10.038. Epub 2016 Nov 27.

PMID:
27899297
14.

Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients.

Prigent G, Aït-Ammar N, Levesque E, Fekkar A, Costa JM, El Anbassi S, Foulet F, Duvoux C, Merle JC, Dannaoui E, Botterel F.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01229-16. doi: 10.1128/AAC.01229-16. Print 2017 Feb.

15.

Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study.

Cassuto E, Pageaux GP, Cantarovich D, Rostaing L, Loupy A, Roche B, Duvoux C, Moreau K, Thervet E, Mazouz H, Bourhis Y, Dharancy S, Kessler M.

Transplantation. 2016 Oct;100(10):2099-2106.

PMID:
27653227
16.

Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT).

Fontaine H, Maynard M, Bouix C, Carrieri MP, Botta-Fridlund D, D'Alteroche L, Conti F, Pageaux GP, Leroy V, Métivier S, Anty R, Durand F, Canva V, Vilotitch A, Lebray P, Alric L, Duvoux C, Petrov-Sanchez V, Beaulieux F, Wellems C, Paul C, Roque-Afonso AM, Roche B, Pradat P, Samuel D, Duclos-Vallée JC; BOCEPRETRANSPLANT study group.

Clin Res Hepatol Gastroenterol. 2017 Feb;41(1):56-65. doi: 10.1016/j.clinre.2016.06.006. Epub 2016 Aug 20.

PMID:
27554134
17.

Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.

Saliba F, Rostaing L, Gugenheim J, Durand F, Radenne S, Leroy V, Neau-Cransac M, Calmus Y, Salamé E, Pageaux GP, Duvoux C, Taguieva N, Sinnasse-Raymond G, Sebagh M, Samuel D, Marquet P.

Transplantation. 2016 Aug;100(8):1705-13. doi: 10.1097/TP.0000000000001228.

PMID:
27454919
18.

Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation.

Dumortier J, Leroy V, Duvoux C, de Ledinghen V, Francoz C, Houssel-Debry P, Radenne S, d'Alteroche L, Fougerou-Leurent C, Canva V, di Martino V, Conti F, Kamar N, Moreno C, Lebray P, Tran A, Besch C, Diallo A, Rohel A, Rossignol E, Abergel A, Botta-Fridlund D, Coilly A, Samuel D, Duclos-Vallée JC, Pageaux GP.

Liver Transpl. 2016 Oct;22(10):1367-78. doi: 10.1002/lt.24505.

19.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

Coilly A, Fougerou-Leurent C, de Ledinghen V, Houssel-Debry P, Duvoux C, Di Martino V, Radenne S, Kamar N, D'Alteroche L, Leroy V, Canva V, Lebray P, Moreno C, Dumortier J, Silvain C, Besch C, Perre P, Botta-Fridlund D, Anty R, Francoz C, Abergel A, Debette-Gratien M, Conti F, Habersetzer F, Rohel A, Rossignol E, Danjou H, Roque-Afonso AM, Samuel D, Duclos-Vallée JC, Pageaux GP; ANRS C023 CUPILT study group.

J Hepatol. 2016 Oct;65(4):711-8. doi: 10.1016/j.jhep.2016.05.039. Epub 2016 Jun 1.

PMID:
27262758
20.

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study.

Belli LS, Berenguer M, Cortesi PA, Strazzabosco M, Rockenschaub SR, Martini S, Morelli C, Donato F, Volpes R, Pageaux GP, Coilly A, Fagiuoli S, Amaddeo G, Perricone G, Vinaixa C, Berlakovich G, Facchetti R, Polak W, Muiesan P, Duvoux C; European Liver and Intestine Association (ELITA).

J Hepatol. 2016 Sep;65(3):524-31. doi: 10.1016/j.jhep.2016.05.010. Epub 2016 May 17.

PMID:
27212241

Supplemental Content

Loading ...
Support Center